Your browser doesn't support javascript.
loading
Assessment of dupilumab in children with moderate-to-severe type 2 asthma with or without evidence of allergic asthma.
Papadopoulos, Nikolaos G; Szefler, Stanley J; Bacharier, Leonard B; Maspero, Jorge F; Domingo, Christian; Fiocchi, Alessandro; Lee, Jason K; Daizadeh, Nadia; Lederer, David J; Hardin, Megan; Gall, Rebecca; Djandji, Michel; Siddiqui, Shahid; Jacob-Nara, Juby A; Deniz, Yamo; Rowe, Paul J.
Afiliação
  • Papadopoulos NG; Allergy Department, The 2nd Pediatric Clinic, University of Athens, Athens, Greece.
  • Szefler SJ; Department of Pediatrics, The Breathing Institute, The University of Colorado School of Medicine and Children's Hospital Colorado, Aurora, Colorado, USA.
  • Bacharier LB; Division of Allergy, Immunology and Pulmonary Medicine, The Monroe Carell Jr. Children's Hospital at Vanderbilt University Medical Center, Nashville, Tennessee, USA.
  • Maspero JF; Allergy and Respiratory Medicine, The Fundación CIDEA, Buenos Aires, Argentina.
  • Domingo C; Pulmonary Service, The Corporació Sanitària Parc Taulí, Sabadell, Autonomous University of Barcelona, Barcelona, Spain.
  • Fiocchi A; Department of Allergy, The Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
  • Lee JK; Division of Adult Clinical Immunology and Allergy, Internal Medicine, Evidence Based Medical Educator and Toronto Allergy and Asthma Clinic, Toronto, Ontario, Canada.
  • Daizadeh N; Sanofi, Cambridge, Massachusetts, USA.
  • Lederer DJ; Regeneron Pharmaceuticals Inc., Tarrytown, New York, USA.
  • Hardin M; Sanofi, Cambridge, Massachusetts, USA.
  • Gall R; Regeneron Pharmaceuticals Inc., Tarrytown, New York, USA.
  • Djandji M; Sanofi, Cambridge, Massachusetts, USA.
  • Siddiqui S; Regeneron Pharmaceuticals Inc., Tarrytown, New York, USA.
  • Jacob-Nara JA; Sanofi, Bridgewater, New Jersey, USA.
  • Deniz Y; Regeneron Pharmaceuticals Inc., Tarrytown, New York, USA.
  • Rowe PJ; Sanofi, Bridgewater, New Jersey, USA.
Allergy ; 78(8): 2157-2167, 2023 08.
Article em En | MEDLINE | ID: mdl-37059696

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Asma / Antiasmáticos Tipo de estudo: Clinical_trials / Diagnostic_studies / Etiology_studies / Prognostic_studies Limite: Child / Humans Idioma: En Revista: Allergy Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Grécia

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Asma / Antiasmáticos Tipo de estudo: Clinical_trials / Diagnostic_studies / Etiology_studies / Prognostic_studies Limite: Child / Humans Idioma: En Revista: Allergy Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Grécia